Document Detail


Hepatic metabolism during constant infusion of fructose; comparative studies with 31P-magnetic resonance spectroscopy in man and rats.
MedLine Citation:
PMID:  8123666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A protocol of constant infusion of fructose has been carried out both in human volunteers and in the perfused rat liver, aiming at a steady-state blood fructose concentration of 6-8 mM. Localized 31P-NMR spectroscopy and biochemical analyses were used to evaluate the metabolic changes. Comparison of the model experiment and the clinical study allowed an evaluation of this protocol as a clinically relevant assessment of the metabolic function of the liver. The time course of change, as well as the quasi steady-state levels reached during fructose infusion, for phosphomonoesters (PME), ATP and inorganic phosphate (Pi) provided the following results: During fructose infusion, ATP and Pi reached a steady-state level of 74.0 +/- 5.9 and 54.6 +/- 3.3% of control respectively, in the human volunteers. The corresponding data in the rat liver was 71.3 +/- 4.3 and 54.4 +/- 4.3%. Hepatic clearance of fructose was 0.53 and 0.52 ml.g liver-1.min-1 for volunteers and rats, respectively. The time course of intracellular metabolite recovery after fructose could be approximated by a first order kinetic. The rate constants for PME and ATP change were similar during fructose infusion and recovery, while after the discontinuation of fructose infusion, Pi increased with a rate constant significantly greater than during its fructose-induced depletion in human liver (P < 0.005). Thus, this relatively simple clinically applicable protocol seems to be verifiable in the well controlled perfused rat liver model, and it is argued that it may be useful in the clinical evaluation of the metabolic functional capacity of the human liver.
Authors:
S Masson; O Henriksen; A Stengaard; C Thomsen; B Quistorff
Related Documents :
12143046 - Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in c...
7493066 - Vasoreactivity of fluosol perfluorocarbon emulsion vs. earl's balanced salt/albumin per...
17002666 - Role of hypothalamic alpha-adrenoceptor activity in fructose-induced hypertension.
3322566 - Calcium content in liver and heart and its intracellular distribution in liver during e...
8514786 - The effects of varying the expression of a neutral cholesteryl ester hydrolase on the t...
9439606 - Suppression of cell growth by heavy chain ferritin.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  1199     ISSN:  0006-3002     ISO Abbreviation:  Biochim. Biophys. Acta     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-04-12     Completed Date:  1994-04-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  166-74     Citation Subset:  IM    
Affiliation:
NMR Centre, Dept. of Medical Biochemistry and Genetics, Copenhagen N, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Fructose / administration & dosage*,  metabolism
Gluconeogenesis
Glycolysis
Humans
Infusions, Intravenous
Liver / metabolism*
Magnetic Resonance Spectroscopy
Male
Perfusion
Phosphorylation
Rats
Rats, Wistar
Chemical
Reg. No./Substance:
30237-26-4/Fructose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantification of protein turnover in primary cultures of rat hepatocytes.
Next Document:  Purification and characterization of calmodulin (lysine 115) N-methyltransferase from Paramecium tet...